Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip S Low

Showing results (11-20 of 305) with videos related to

Pageof 31
Sort By:
Cancer Immunology, Immunotherapy : CII|April 10, 2002
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumorsYingjuan Lu, Philip S Low
Bioorganic & Medicinal Chemistry Letters|March 21, 2015
Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancersGuo Li, Philip S Low
Chemical Reviews|September 13, 2017
Ligand-Targeted Drug DeliveryMadduri Srinivasarao, Philip S Low
Advanced Drug Delivery Reviews|April 20, 2004
Folate receptor-targeted drugs for cancer and inflammatory diseasesPhilip S Low, Asok C Antony
Journal of Pharmaceutical Sciences|September 2, 2005
Folate receptor-mediated drug targeting: from therapeutics to diagnosticsAndrew R Hilgenbrink, Philip S Low
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
Targeting of nanoparticles: folate receptorSumith A Kularatne, Philip S Low
The Journal of Biological Chemistry|December 17, 2002
Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesisSeon Hee Chang, Philip S Low
Cancer Metastasis Reviews|June 5, 2008
Tumor detection using folate receptor-targeted imaging agentsEmanuela I Sega, Philip S Low
Molecular Pharmaceutics|October 4, 2017
Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing CancersAnanda Kumar Kanduluru, Philip S Low
The Biochemical Journal|July 21, 2016
Identification of adducin-binding residues on the cytoplasmic domain of erythrocyte membrane protein, band 3Taina Franco, Haiyan Chu, Philip S Low
Pageof 31

Showing results (11-20 of 305) with videos related to

Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|April 10, 2002
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumorsYingjuan Lu, Philip S Low
Bioorganic & Medicinal Chemistry Letters|March 21, 2015
Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancersGuo Li, Philip S Low
Chemical Reviews|September 13, 2017
Ligand-Targeted Drug DeliveryMadduri Srinivasarao, Philip S Low
Advanced Drug Delivery Reviews|April 20, 2004
Folate receptor-targeted drugs for cancer and inflammatory diseasesPhilip S Low, Asok C Antony
Journal of Pharmaceutical Sciences|September 2, 2005
Folate receptor-mediated drug targeting: from therapeutics to diagnosticsAndrew R Hilgenbrink, Philip S Low
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
Targeting of nanoparticles: folate receptorSumith A Kularatne, Philip S Low
The Journal of Biological Chemistry|December 17, 2002
Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesisSeon Hee Chang, Philip S Low
Cancer Metastasis Reviews|June 5, 2008
Tumor detection using folate receptor-targeted imaging agentsEmanuela I Sega, Philip S Low
Molecular Pharmaceutics|October 4, 2017
Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing CancersAnanda Kumar Kanduluru, Philip S Low
The Biochemical Journal|July 21, 2016
Identification of adducin-binding residues on the cytoplasmic domain of erythrocyte membrane protein, band 3Taina Franco, Haiyan Chu, Philip S Low
Pageof 31